These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2468230)

  • 1. Toxic effects on renal cells in culture--a comparison of cyclosporin A and its metabolites.
    Cole E; Cheung F; Wong PY; Fung LS; Skorecki K; Levy GA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):943-5. PubMed ID: 2468230
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of cyclosporine A, cyclosporine G, and FK 506 upon prostaglandin production in renal mesangial cells in culture.
    McCauley J; Studer R; Craven P; Murray S
    Transplant Proc; 1991 Dec; 23(6):3141-2. PubMed ID: 1721384
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporin A metabolites suppress T-cell proliferation by concanavalin A and in a mixed lymphocyte reaction.
    Abecassis M; Wong PY; Mason N; Cheung F; Mee AV; Cole EH; Langer B; Cohen Z; Levy GA
    Can J Surg; 1988 May; 31(3):145-50. PubMed ID: 2966666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of cyclosporine G (OG37-325), cyclosporine A, and their metabolites on the release of vasoactive substances from primary renal cell lines.
    Langman LJ; Yatscoff RW
    Transplant Proc; 1994 Oct; 26(5):3002-5. PubMed ID: 7940948
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of cyclosporine metabolites in therapeutic monitoring and immunosuppression.
    Rosano TG; Freed BM; Pell MA; Dybas MT; Lempert N
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1699-703. PubMed ID: 2950633
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporin A suppresses proliferation of renal mesangial cells in culture.
    Martin M; Krichbaum M; Kaever V; Goppelt-Strübe M; Resch K
    Biochem Pharmacol; 1988 Mar; 37(6):1083-8. PubMed ID: 3355584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
    Chiba K; Nishimura T; Hashimoto Y
    J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine induced alterations in vasopressin signalling in the glomerular mesangial cell.
    Kremer S; Margolis B; Harper P; Skorecki K
    Clin Invest Med; 1989 Jun; 12(3):201-6. PubMed ID: 2743638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of an endogenous pyrogen by glomerular mesangial cells.
    Lovett DH; Sterzel RB; Ryan JL; Atkins E
    J Immunol; 1985 Feb; 134(2):670-2. PubMed ID: 3871212
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of suppressor T lymphocytes in the induction of specific immunologic unresponsiveness to rat cardiac allografts by donor leukocytes and cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1038-44. PubMed ID: 2968694
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture.
    Freed BM; Rosano TG; Quick C; Lempert N
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1223-6. PubMed ID: 2950629
    [No Abstract]   [Full Text] [Related]  

  • 12. The splenic suppressor cell. I. Activity of thymus-dependent adherent cells: changes with age and stress.
    Folch H; Waksman BH
    J Immunol; 1974 Jul; 113(1):127-39. PubMed ID: 4275547
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
    Copeland KR; Yatscoff RW; Rush D; Jeffery JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporin A.
    Morris PJ
    Transplantation; 1981 Nov; 32(5):349-54. PubMed ID: 6460358
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure--activity relationships of the didemnins.
    Sakai R; Rinehart KL; Kishore V; Kundu B; Faircloth G; Gloer JB; Carney JR; Namikoshi M; Sun F; Hughes RG; García Grávalos D; de Quesada TG; Wilson GR; Heid RM
    J Med Chem; 1996 Jul; 39(14):2819-34. PubMed ID: 8709112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive and synergistic effects of cyclosporine metabolites on glomerular mesangial cells.
    Radeke HH; Christians U; Bleck JS; Sewing KF; Resch K
    Kidney Int; 1991 Jun; 39(6):1255-66. PubMed ID: 1895678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine pharmacokinetics and pharmacodynamics after oral administration in the rat.
    Didlake RH; Kim EK; Grevel J; Jarolimek L; Kahan BD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):692-5. PubMed ID: 2966483
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of prolonged allograft survival induced by ultraviolet B irradiated donor-specific blood transfusions and cyclosporine.
    Oluwole SF; Reemtsma K; Hardy MA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1097-101. PubMed ID: 2968697
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of taurocholate transport by cyclosporin A in cultured rat hepatocytes.
    Kukongviriyapan V; Stacey NH
    J Pharmacol Exp Ther; 1988 Nov; 247(2):685-9. PubMed ID: 3183963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxic and immunosuppressive potentials of cyclosporine metabolites in rats.
    Ryffel B; Hiestand P; Foxwell B; Donatsch P; Boelsterli HJ; Maurer G; Mihatsch MJ
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):41-5. PubMed ID: 3787715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.